Bezafibrate clinical trials cholesterol lowering intervention

DNS-X - , fluorescent bezafibrate - Azufibrat - Solibay - Sklerofibrat - Regadrin B - Reducterol - Lipox - Béfizal - Difaterol - Cedur - BM15.075 - BM 15.075 - BM-15.075 - durabezur - Bezamerck - Eulitop - Bezalip - Bezafisal - Bezafibrat PB - Bezacur - Bezabeta - BezaPuren - Beza Puren - Beza-Puren - BezaLande - Beza Lande - Beza-Lande - Befibrat

Cardiovascular prevention

All chronical situations:  5 trials  - LEADER - BIP - LEADER trial - SENDCAP - BECAIT

All type of patients:  4 trials  - LEADER - BIP - SENDCAP - BECAIT

Diabetic patients :  1 trials  - SENDCAP

Patients with other atherosclerotic localisation:  1 trials  - LEADER

Patients with prior MI or with CHD:  1 trials  - SENDCAP

Peripheral vascular diseases

1 trials  - LEADER trial

Post myocardial infarction

2 trials  - BIP - BECAIT